New England Journal / T. If / John Wiley & Sons Ltd. / Wiley InterScience / / /
Event
FDA Phase / /
Facility
National Cancer Institute / Rockville Pike / /
IndustryTerm
treatment / genomic technologies / cient technologies / cancer treatment / biomarker-based classi cation systems / diagnostic medical applications / control / /
MedicalCondition
use large B-cell lymphoma identi ed / cancers / large B-cell lymphoma outcome prediction / cancer / molecular disease / tumors / disease / mantle cell lymphoma / advanced lung cancer / solid tumors / genomically unstable tumors / diseases / breast cancer / common diseases / use large B-cell lymphoma / human breast tumours / /
MedicalTreatment
chemotherapy / /
Organization
National Cancer Institute / /
Person
Richard Simon / /
Position
Fisher / /
Product
Iressa / /
ProgrammingLanguage
R / /
PublishedMedium
American Journal of Human Genetics / Nature Medicine / New England Journal of Medicine / Journal of Clinical Oncology / /
RadioStation
Balis FM / /
Region
New England / /
Technology
genomics / drug metabolism / genomics-based technologies / drug discovery / DNA Chip / hybridization / gene expression / DNA sequencing / chemotherapy / cient technologies / machine learning / genotyping / genotype / drug development / Genomic technologies / /
STATISTICS IN MEDICINE Statist. Med. 2005; 24:329–339 Published online 18 November 2004 in Wiley InterScience (www.interscience.wiley.com). DOI: [removed]sim.1975 On the eciency of targeted clinical trials A. Maitourna